William Thomsen

William Thomsen, Ph.D. is principal scientist in SRI International's Center for Advanced Drug Research, based in SRI Shenandoah Valley. He leads the Center's metabolic diseases research group.

Thomsen has more than 25 years of experience in pharmaceutical drug discovery, with an emphasis on target validation, assay development, high-throughput screening, and molecular pharmacology. He has experience with several classes of discovery targets, including G protein coupled receptors, within multiple therapeutic areas, including: disorders of the central nervous system; endocrine, metabolic, cardiovascular, and immunological diseases; and cancer. Before joining SRI, he served as the director of molecular pharmacology at Arena Pharmaceuticals.

Thomsen received his Ph.D. from the University of Michigan and was a postdoctoral fellow at the University of Washington.